Michaela Liedtke

14.1k citations
171 papers · 5.2k · 3 hit papers · h-index 38

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
    • Chronic Myeloid Leukemia Treatments
  • Oncology top 1%
    • CAR-T cell therapy research
    • Peptidase Inhibition and Analysis

Papers in

    • Amyloidosis: Diagnosis, Treatment, Outcomes 59
    • Multiple Myeloma Research and Treatments 51
    • Acute Myeloid Leukemia Research 23
    • Chronic Myeloid Leukemia Treatments 16

Michaela Liedtke

159 papers receiving 5.1k citations

Michaela Liedtke's Hit Papers

Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results 2023 · 177 citations
1770+3+6Years since publication250500750

Peers

Michaela Liedtke
Comparison fields: 5 of 105
  • Hematology 1.5k
  • Oncology 2.0k
  • Genetics 525
  • Public Health, Environmental and Occupational Health 1.1k
  • Nephrology 234
Replace Stefan Knop with:
Stefan Knop Germany
Tibor Kovacsovics United States
Michel Delforge Belgium
Patrizia Tosi Italy
Lia Gore United States
Luca Laurenti Italy
Robert A. Bray United States
Francesco Buccisano Italy
Bruno Paiva Spain
Torben Plesner Denmark
Michaela Liedtke relative to Stefan Knop Germany Stefan Knop's profile →
Citations per field
00.5×5.8×
Stefan Knop · 1×
Citations per year

Countries citing papers authored by Michaela Liedtke

Since Specialization
Citations

This map shows the geographic impact of Michaela Liedtke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaela Liedtke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaela Liedtke more than expected).

Fields of papers citing papers by Michaela Liedtke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaela Liedtke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaela Liedtke. The network helps show where Michaela Liedtke may publish in the future.

Co-authors

The 25 scholars most cited alongside Michaela Liedtke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michaela Liedtke Line = papers co-authored together Michaela Liedtke links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
Hit paper breakdown →
2016901
2 2019273
3
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study
Hit paper breakdown →
2019237
4 2017179
5
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Hit paper breakdown →
2023177
6 2016149
7 2013147
8 1992118
9 2014114
10 2013108
11 2017101
12 201795
13 201590
14 200979
15 202173
16 200672
17 202072
18 201165
19 200964
20 201563

About Michaela Liedtke

Michaela Liedtke is a scholar working on Molecular Biology, Hematology, Oncology, Public Health, Environmental and Occupational Health and Genetics, having authored 171 papers that have together received 5.2k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (59 papers), Multiple Myeloma Research and Treatments (51 papers), Acute Lymphoblastic Leukemia research (40 papers), CAR-T cell therapy research (29 papers), Chronic Lymphocytic Leukemia Research (28 papers), Acute Myeloid Leukemia Research (23 papers), Chronic Myeloid Leukemia Treatments (16 papers) and Neuroendocrine Tumor Research Advances (16 papers). The work is most often cited by research in Hematology (1.5k citations), Oncology (2.0k citations), Genetics (525 citations), Public Health, Environmental and Occupational Health (1.1k citations) and Nephrology (234 citations). Michaela Liedtke has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Ronald Witteles, Anjali S. Advani, Daniel J. DeAngelo, Wendy Stock, Erik Vandendries, Hagop M. Kantarjian, Matthias Stelljes, Nicola Gökbuget, Susan O’Brien and Barbara Sleight. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Haematologica and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact